Surgical Management of Cervical Non‐seminomatous Germ Cell Tumor Metastases

• Published in: The Laryngoscope 2021-07, Vol.131 (7), p.1528-1534
• Main Authors: Nwosu, Obi I., Jones, Alexander J., Alwani, Mohamedkazim, Einhorn, Lawrence H., Moore, Michael G., Mantravadi, Avinash V.
• Format: Article
• Language: English
• Subjects: Head & neck cancer; head and neck cancer; Laryngoscopy; Metastasis; neck dissection; Non‐seminomatous germ cell tumor; Testicular cancer; Thoracic surgery
• ISSN: 0023-852X; 1531-4995
• DOI: 10.1002/lary.29364

Objective/Hypothesis Testicular cancer is the most common malignancy of young males. Limited reports describe perioperative and long‐term outcomes after surgical resection of metastatic, cervical, non‐seminomatous germ cell tumors (NSGCT). The objective of this study was to investigate the effectiveness and safety of cervical lymphadenectomy in the management of metastatic NSGCT. Study Design Retrospective case series. Methods A single institution, retrospective review from 1998 to 2020 of patients with metastatic NSGCT who underwent cervical lymphadenectomy was conducted. Clinicopathological, surgical, and postoperative data were collected and analyzed. Results Sixty‐eight predominantly white (91.0%) male patients with mean age 33.0 ± 11.3 years were included. Most (82.2%) presented with stage III disease at initial diagnosis. All patients had undergone primary platinum‐based chemotherapy 1.0 to 22.7 months prior to selective ND. Surgery mainly involved nodal levels III (67.6%), IV (92.6%) and/or Vb (77.9%) and was frequently performed with concomitant thoracoabdominal NSGCT resections (63.2%). Cervical specimens predominantly revealed mature teratoma (83.8%) as solitary (69.1%) or component of mixed (14.7%) NSGCT. Ten (14.7%) perioperative complications occurred as vocal cord paresis (n = 6) from thoracic surgery and chyle leakage (n = 4). All resolved conservatively except two vocal cord paralyzes that required surgical repair due to tumor involvement of vagus nerve. Six instances of cervical recurrence occurred at median 12.5 (range, 5.8–38.6) months from ND, all re‐demonstrating purely mature teratoma. The two‐year cervical, non‐cervical, and overall recurrence‐free survivals were 83%, 55%, and 55%, respectively. Two‐year disease‐free and overall survivals were both 93%. Conclusions Selective neck dissection is a safe, effective method for managing cervical NSGCT metastases. Level of Evidence 4 Laryngoscope, 131:1528–1534, 2021